Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research

Psychosomatic Medicine

Volumn 73, Issue 2, 2011, Pages 114-126

  Stetler, Cinnamon ^a   Miller, Gregory E ^b  

^a FURMAN UNIVERSITY   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

adrenocorticotropic hormone; corticotropin releasing hormone; cortisol; depression; hypothalamic pituitary adrenal axis; meta analysis

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; ATYPICAL DEPRESSION; BECK DEPRESSION INVENTORY; BLOOD CEREBROSPINAL FLUID BARRIER; CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE; CHILD; CIRCADIAN RHYTHM; DEMOGRAPHY; DEPRESSION; DEPRESSIVE PSYCHOSIS; ENDOGENOUS DEPRESSION; FEMALE; GENDER; HAMILTON SCALE; HOSPITALIZATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MELANCHOLIC DEPRESSION; META ANALYSIS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTPATIENT; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SALIVA LEVEL; SCHOOL CHILD; ZUNG DEPRESSION SCALE;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; BIBLIOMETRICS; CHILD; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; RESEARCH;

EID: 79951514630     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31820ad12b     Document Type: Article

References (35)

1. Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008;31:464-8
2. Thase ME, Jindal R, Howland RH. Biological aspects of depression. In: Gotlieb IH, Hammen CL, editors. Handbook of Depression. New York: Guilford Press; 2002
3. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness (Pubitemid 38045427)
4. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. Orlando, FL: Academic Press; 1985
5. Kalaian HA, Raudenbush SW. A multivariate mixed linear model for meta-analysis. Psychol Methods 1996;1:227-35 (Pubitemid 126670221)
6. Hedges LV, Vevea JL. Fixed and random-effects models in meta-analysis. Psychol Methods 1998;3:486-504
7. Raudenbush S, Bryk A, Congdon R. HLM 6: Hierarchical Linear and Nonlinear Modeling [computer software]. Chicago: Scientific Software International; 2000
8. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988
9. Burke HM, Davis MC, Otte C, Mohr DC. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocri-nology 2005;30:846-56 (Pubitemid 40977907)
10. Schule C. Neuroendocrinological mechanisms of actions of antidepres-sant drugs. J Neuroendocrinol 2007;19:213-26 (Pubitemid 46210949)
11. Schule C, Baghai TC, Eser D, Rupprecht R. Hypothalamic-pituitary- adrenocortical system dysregulation and new treatment strategies in depression. Expert Rev Neurother 2009;9:1005-19
12. Binneman B, Feltner D, Kolluri S, Shi Y, Qiu R, Stiger T. A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression. Am J Psychiatry 2008; 165:617-20 (Pubitemid 351705339)
13. Kaltsas GA, Chrousos G. The neuroendocrinology of stress. In: Cacioppo JT, Tassinary LG, Bersani G, editors. Handbook of Psychophysiology. 3rd ed. Cambridge: Cambridge University Press; 2007
14. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotrop-in-releasing factor. Pharmacol Rev 1991;43:425-73
15. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 1993;113:472-86
16. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171-86
17. McKay MS, Zakzanis KK. The impact of treatment on HPA axis activity in unipolar major depression. J Psychiatr Res 2009.
18. Miller GE, Chen E, Zhou ES. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psy-chol Bull 2007;133:25-45
19. Bornstein SR, Chrousos GP. Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab 1999;84:1729-36 (Pubitemid 30644284)
20. Dickerson SS, Kemeny ME. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol Bull 2004;130:355-91 (Pubitemid 38614661)
21. Taylor SE. Hospital patient behavior: reactance, helplessness, or control? In: Friedman HS, DiMatteo MR, editors. Interpersonal Issues in Health Care. New York: Academic Press; 1982
22. Matza LS, Revicki DA, Davidson JR, Stewart JW. Depression with atypical features in the national comorbidity survey: classification, description, and consequences. Arch Gen Psychiatry 2003;60:817-26 (Pubitemid 36960913)
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association; 1994
24. Gold PW, Chrousos GP. Organization of the stress system and its dys-regulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 2002;7:254-75 (Pubitemid 34280634)
25. Rush AJ, Weissenburger JE. Melancholic symptom features and DSM-IV. Am J Psychiatry 1994;151:489-98 (Pubitemid 24115811)
26. Ohayon MM, Schatzberg AF. Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry 2002;159: 1855-61 (Pubitemid 35283250)
27. Nelson JC, Davis CL. DST studies in psychotic depression: a meta-analysis. Am J Psychiatry 1997;154:1497-503
28. Fleming SK, Blasey C, Schatzberg AF. Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis. J Psychiatr Res 2004;38:27-35 (Pubitemid 38018987)
29. Frasure-Smith N, Lesperance F. Reflections on depression as a cardiac risk factor. Psychosom Med 2005;67 Suppl 1:S19-S25 (Pubitemid 40721027)
30. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4-11 (Pubitemid 28037542)
31. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, Frasure-Smith N, Glassman AH, Gold PW, Grant I, Gwyther L, Ironson G, Johnson RL, Kanner AM, Katon WJ, Kaufmann PG, Keefe FJ, Ketter T, Laughren TP, Leserman J, Lyketsos CG, McDonald WM, McEwen BS, Miller AH, Musselman D, O'Connor C, Petitto JM, Pollock BG, Robinson RG, Roose SP, Rowland J, Sheline Y, Sheps DS, Simon G, Spiegel D, Stunkard A, Sunderland T, Tibbits P Jr, Valvo WJ. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005;58:175-89 (Pubitemid 41112265)
32. Jokinen J, Nordström P. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. J Affect Disord 2009;116:88-92
33. Rosmond R, Bjorntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med 2000;247:188-97 (Pubitemid 30108352)
34. Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NP, Thakur M, McEwen BS, Hauger RL, Meaney MJ. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998;1:69-73 (Pubitemid 128652645)
35. Miller G, Chen E, Cole SW. Health psychology: developing biologically plausible models linking the social world and physical health. Annu Rev Psychol 2009;60:501-24